Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


SpectraMax Paradigm

Product Description
The SpectraMax® Paradigm® Microplate Reader has been designed to be consistent in performance and provides the flexibility and sensitivity needed to quickly develop and run your assays, both now and in the future. 

The SpectraMax® Paradigm® offers several cartridge options which can be combined to create your own customisable microplate reader to suit your needs meaning that you do not have to compromise your research. The SpectraMax® Paradigm® has two cartridge draws, each which can hold up to 6 cartridges meaning your custom microplate reader can hold up to 12 cartridges and perform a multitude of applications. Although your detection needs may change, your equipment can stay the same simply by adding a new detection cartridge.

Detection Cartridge Options
Every detection cartridge starts with a wavelength-tuned excitation energy source either in the form of long-life, high-powered LED or xenon flash lamp. Concentrating the excitation energy on the sample through label-specific optics, high levels of sensitivity and performance are reached. All this combined in the detection cartridge creates the ultimate no-compromise multimode detection platform.

If you cannot locate a detection cartridge that meets your application needs, contact us to discuss a Custom Cartridge.
Product SpectraMax Paradigm
Company Molecular Devices Product Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Molecular Devices Product Directory
1311 Orleans Drive Sunnyvale, CA 94089-11361 United States

Tel: 1-800-635-5577
Fax: 1-408-548-6439
Email: om@moldev.com



Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Protein-Based “Cancer Signature” Uncovered
Researchers investigated the expression of ribosomal proteins in human tissues and discovered a cancer type specific signature which could be used to predict the progression of the disease.
Ribosome Recycling as a Drug Target
Researchers explain mechanism that recycles bacterial ribosomes stalled on messenger RNAs that lack termination codons.
Predicting Leukaemia Development in Cancer Patients
Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia.
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Toxoplasma’s Balancing Act Explained
Parasite’s method of rewiring our immune response leads to novel tool for drug tests.
Cancer Signaling Pathway Illuminating Way To Therapy
Researchers refine a pro-growth signalling pathway, common to cancers, that can kill cancer cells while leaving healthy cells unharmed.
Breast Cancer Cells Starve for Cystine
Depriving triple negative breast cancer, a treatment-resistant form of breast cancer, of cystine results in cancer cell death.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!